EUVIMEDEUVIMED entdecken
Crossref

Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model

Qifan Huang, Zhentong Lu, Castiel Chen Zhuang iD

Health Economics · 2025

DOI: 10.1002/hec.70073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Economics, 2025. Verfasst von Qifan Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Meta Platforms Inc., Menlo Park, California, USA. Hauptthemen laut MEDLINE: Health Policy, Practice Patterns, Physicians', Prescription Drugs. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University School of Economics Research Seed Grant, Fundamental Research Funds for the Central Universities, Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper quantifies physician agency in China's prescription drug market by exploiting the structural shift created by the Zero‐Markup Drug Policy. We find that physicians' prescribing decisions are about three times more sensitive to the hospital's profit margin than to the retail price faced by patients. The study provides several key findings. First, government policy exerts a strong influence on drug prices. Second, branded drugs are generally preferred over generics and display lower price elasticity. Third, the policy accounts for more than half of the observed decline in average wholesale prices. Finally, while the policy improves patient welfare, it reduces pharmaceutical firms' sales and profits, and a partial restoration of drug markups could increase overall social welfare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PolicyPractice Patterns, Physicians'Prescription DrugsChinaHumansDrug IndustryDrug Costs

Stichwörter der Autor:innen

hyperlipidemiaphysician agencystructural analysis

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Meta Platforms Inc., Menlo Park, California, USA.
  • Bank of Canada, Ottawa, Ontario, Canada.
  • Peking University School of Economics, Beijing, China.

ORCID-Profile: Castiel Chen Zhuang

Förderung

  • National Natural Science Foundation of China
  • Peking University School of Economics Research Seed Grant
  • Fundamental Research Funds for the Central Universities, Peking University

Zitieren

APA

Huang, Q., Lu, Z., & Zhuang, C. C. (2025). Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. https://doi.org/10.1002/hec.70073

Vancouver

Huang Q, Lu Z, Zhuang CC. Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model. Health Economics. 2025. doi:10.1002/hec.70073

BibTeX
@article{Huang2025,
  author = {Huang, Qifan and Lu, Zhentong and Zhuang, Castiel Chen},
  title = {Physician Agency and the Zero‐Markup Drug Policy in China: Evidence From a Structural Model},
  journal = {Health Economics},
  year = {2025},
  doi = {10.1002/hec.70073}
}
Kostenlos starten →